Understanding brain function requires advanced neural probes to monitor electrical and chemical signaling across multiple timescales and brain regions. Microelectrode arrays (MEAs) are widely used to record neurophysiological activity across various depths and brain regions, providing single-unit resolution for extended periods. Recent advancements in flexible MEAs, built on micrometer-thick polymer substrates, have improved integration with brain tissue by mimicking the brain’s soft nature, reducing mechanical trauma and inflammation. These flexible, subcellular-scale MEAs can record stable neural signals for months, making them ideal for long-term studies. In addition to electrical recording, MEAs have been functionalized for electrochemical neurotransmitter detection. Electroactive neurotransmitters, such as dopamine, serotonin, and adenosine, can be directly measured via electrochemical methods, particularly on carbon-based surfaces. For non-electroactive neurotransmitters like acetylcholine, glutamate, and γ-aminobutyric acid, alternative strategies, such as enzyme immobilization and aptamer-based recognition, are employed to generate electrochemical signals. This review highlights recent developments in flexible MEA fabrication and functionalization to achieve both electrochemical and electrophysiological recordings, minimizing sensor fowling and brain damage when implanted long-term. It covers multi-time scale neurotransmitter detection, development of conducting polymer and nanomaterial composite coatings to enhance sensitivity, incorporation of enzyme and aptamer-based recognition methods, and the integration of carbon electrodes on flexible MEAs. Finally, it summarizes strategies to acquire electrochemical and electrophysiological measurements from the same device.
Understanding brain function requires advanced neural probes to monitor electrical and chemical signaling across multiple timescales and brain regions. Microelectrode arrays (MEAs) are widely used to record neurophysiological activity across various depths and brain regions, providing single-unit resolution for extended periods. Recent advancements in flexible MEAs, built on micrometer-thick polymer substrates, have improved integration with brain tissue by mimicking the brain's soft nature, reducing mechanical trauma and inflammation. These flexible, subcellular-scale MEAs can record stable neural signals for months, making them ideal for long-term studies. In addition to electrical recording, MEAs have been functionalized for electrochemical neurotransmitter detection. Electroactive neurotransmitters, such as dopamine, serotonin, and adenosine, can be directly measured via electrochemical methods, particularly on carbon-based surfaces. For non-electroactive neurotransmitters like acetylcholine, glutamate, and γ-aminobutyric acid, alternative strategies, such as enzyme immobilization and aptamer-based recognition, are employed to generate electrochemical signals. This review highlights recent developments in flexible MEA fabrication and functionalization to achieve both electrochemical and electrophysiological recordings, minimizing sensor fowling and brain damage when implanted long-term. It covers multi-time scale neurotransmitter detection, development of conducting polymer and nanomaterial composite coatings to enhance sensitivity, incorporation of enzyme and aptamer-based recognition methods, and the integration of carbon electrodes on flexible MEAs. Finally, it summarizes strategies to acquire electrochemical and electrophysiological measurements from the same device.
Nitric oxide (NO) regulates neuronal signaling and neurovascular function, but its rapid diffusion, short lifetime, and reactivity complicate real-time detection in tissue. We developed flexible platinum microelectrode arrays (MEAs) modified with nanostructured platinum (nano-Pt) and a permselective poly(m-phenylenediamine) (mPD) coating for sensitive, selective NO monitoring. Nano-Pt electrodeposition reduced impedance approximately eightfold at 10 Hz and increased charge-storage capacity approximately 7.4-fold without increasing electrode dimensions. Simultaneous amperometric recordings from multiple electrode channels demonstrated the multisite sensing proof of concept of the flexible MEA platform. Amperometric calibration showed linear responses from 50 to 250 nM (R2 > 0.999), with a sensitivity of 243.16 ± 6.12 pA/µM and an operational detection limit of 50 nM. The mPD coating attenuated responses to ascorbic acid, uric acid, and dopamine. Sensors retained NO sensitivity (180 ± 8.6 pA/µM) in endothelial cell culture medium and detected transients following exposure of primary brain microvascular endothelial cells to copper-containing high-aspect-ratio structures (CuHARS), corresponding to peak NO-equivalent concentrations of 320 ± 50 nM. In mouse hippocampus, local NMDA/glycine administration evoked responses corresponding to estimated NO concentrations of 154 ± 31 nM. Finite-element simulations predicted detectable NO concentration gradients across neighboring electrode sites. These results support flexible nano-Pt/mPD MEAs for NO monitoring in complex biological environments and motivate experimental validation of spatially resolved measurements.